Mark A. Berman - Dec 18, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Medical Officer
Signature
/s/ Leslie Miller, Attorney-in-fact
Stock symbol
BTTX
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 05:10 PM
Previous filing
Jul 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +25.4K +6% $0.00 448K Dec 18, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting person was awarded 25,362 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
F2 Includes 34,587 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.